The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Endocyte
Leadership - Endocyte
Stock and Other Ownership Interests - Endocyte
Phase 1 dose escalation study of the folate receptor-targeted small molecule drug conjugate EC1456.
 
Wael A. Harb
No Relationships to Disclose
 
Martin J. Edelman
Stock and Other Ownership Interests - Biomarker Strategies
Consulting or Advisory Role - ARIAD; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Lilly; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Endocyte (Inst); Genentech/Roche (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - ARIAD; Hospira; Lilly
Other Relationship - AstraZeneca/MedImmune; Boehringer Ingelheim; Lilly; Synta
 
Setsuko K. Chambers
No Relationships to Disclose
 
Linda L. Garland
No Relationships to Disclose
 
Alison Armour
No Relationships to Disclose
 
Ding Wang
No Relationships to Disclose
 
Glenwood D. Goss
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Pfizer
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer
 
Jasgit Sachdev
No Relationships to Disclose